title: Pharmacokinetics of flubendazole and its metabolites in lambs and adult sheep (Ovis aries).
abstract: Flubendazole (FLU) is indicated for control of helminthoses in pig and avian species (monogastric animals) and its corresponding pharmacokinetics are well known. The information on FLU's pharmacokinetic behavior in animal species with forestomach (ruminants) has been limited although the use of FLU in these species could be beneficial. The aim of this study was to investigate the pharmacokinetics of FLU and its main metabolites in sheep. The effects of animal age (sexually immature and mature ones) and gender were also studied. FLU was orally administered in a single experimental dose (30 mg/kg of body weight) in the form of oral suspension. Treated immature animals (aged 3 months) and 5 months later the same mature individuals (aged 8 months) were kept under the same conditions (food, water and management) and treated with FLU. Within 72 h after FLU administration, plasmatic samples were collected and FLU and its Phase I metabolites were quantified using high-performance liquid chromatography. FLU was detected in very low concentrations only, reduced FLU (FLU-R) was identified as the main metabolite, and hydrolyzed FLU (FLU-H) as the minor one. Formation of FLU-R was stereospecific with (+)-FLU-R domination. The plasmatic concentrations of (+)-FLU-R reached 10-15 times higher values than those of FLU, (-)-FLU-R and FLU-H. A significant gender effect on pharmacokinetics of FLU or (+)-FLU-R metabolite in the mature animals was found and a wide significant difference between lambs and adult sheep in FLU including both metabolites has been proved.
authors.affiliation: Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic.
authors.forename: V
authors.initials: V
authors.lastname: Krízová
authors.forename: M
authors.initials: M
authors.lastname: Nobilis
authors.forename: L
authors.initials: L
authors.lastname: Prusková
authors.forename: J
authors.initials: J
authors.lastname: Chládek
authors.forename: B
authors.initials: B
authors.lastname: Szotáková
authors.forename: V
authors.initials: V
authors.lastname: Cvilink
authors.forename: L
authors.initials: L
authors.lastname: Skálová
authors.forename: J
authors.initials: J
authors.lastname: Lamka
mesh_terms: D000375:Aging; D000818:Animals; D000969:Antinematodal Agents / Q000097:blood / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics*; D005260:Female; D008297:Male; D008463:Mebendazole / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics; D015394:Molecular Structure; D012756:Sheep
chemical_list: D000969:Antinematodal Agents; D008463:Mebendazole; C018945:flubendazole